HDACs could be recruited to the miRNAs promoter, for example, HDAC2 was reported in esophageal squamous cell carcinoma to suppress the expression level of miR-182 via bonding to the miR-182 promoter and also inhibit miR-133 in neuroblastoma [23, 24]. Here, HDAC2 is linked to neuroblastoma.